ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0743

Are Genetic Causes of Proteinuric Kidney Disease More Common in Patients with Echogenic Kidneys?

Session Information

Category: Pediatric Nephrology

  • 1900 Pediatric Nephrology

Authors

  • Lal, Kirshan, Children's Hospital at Montefiore, New York, New York, United States
  • Tollaksen, Ross A., Children's Hospital at Montefiore, New York, New York, United States
  • Amodio, John, Children's Hospital at Montefiore, New York, New York, United States
  • Agalliu, Ilir, Children's Hospital at Montefiore, New York, New York, United States
  • Kaskel, Frederick J., Children's Hospital at Montefiore, New York, New York, United States
  • Reidy, Kimberly J., Children's Hospital at Montefiore, New York, New York, United States
Background

In children with nephrotic syndrome, echogenic kidneys have been associated with increased steroid resistance and worse outcomes, but the association with genetic mutations has not been studied. We hypothesized that genetic causes of proteinuria and/or nephrotic syndrome (NS) will be more common in patients with persistent echogenic kidneys on ultrasound.

Methods

We are performing a retrospective cross-sectional study including patients aged 0-21 years old seen at Children’s Hospital at Montefiore Einstein pediatric nephrology clinic between 01/01/2010-12/31/2023. Inclusion criteria are a diagnosis of proteinuria or NS confirmed by chart review with renal ultrasound imaging and genetic testing results available. Exclusion criteria include patients with kidney transplant at the time of diagnosis of NS or proteinuria or with systemic secondary causes (eg. Lupus). The primary outcome is the presence or absence of pathogenic mutations between subjects with echogenic vs. non-echogenic kidneys.

Results

In a preliminary analysis of 72 subjects, 72% had echogenic kidneys and 35% had positive genetic testing. Using a Mann Whitney U test, subjects with positive genetic mutations had a statistically significant lower eGFR at diagnosis (p < 0.05). In contrast, there was no statistical difference between in eGFR at diagnosis between subjects with echogenic vs. non-echogenic kidneys. Additional data collection and detailed chart review is ongoing.

Conclusion

This study may help us better understand how to identify patients with genetic causes NS and improve our screening protocols for genetic causes of NS/proteinuria.

Digital Object Identifier (DOI)